Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 62,950 |
| Receivables | 890 |
| Other current assets | 350 |
| TOTAL | $64,190 |
| Non-Current Assets | |
| PPE Net | 430 |
| Other Non-Current Assets | 9 |
| TOTAL | $439 |
| Total Assets | $64,300 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 3,250 |
| Accrued Expenses | 1,400 |
| Other current liabilities | 29,810 |
| TOTAL | $38,480 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 1,700 |
| TOTAL | $1,700 |
| Total Liabilities | $40,180 |
| Shareholders' Equity | |
| Common Shares | 10 |
| Retained earnings | -71,490 |
| Other shareholders' equity | 19,150 |
| TOTAL | $24,110 |
| Total Liabilities And Equity | $64,290 |